

Clinician's Roundtable
ReachMD
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
Episodes
Mentioned books

May 1, 2008 • 0sec
Lessons from the Alligators
Host: Shira Johnson, MD
Guest: Mark Merchant, PhD
Dr. Shira Johnson interviews Dr. Mark Merchant on his recent research into the immunity of alligators in their natural habitat. Listen to learn what the implications are for future work with topical products in burn research and more. Why is alligator serum effective against HIV in vitro and is there a take home message for human research in all of this work?

May 1, 2008 • 0sec
Aortic Valve Disease: The Role of Hemodynamic Measurements
Host: Matthew J. Sorrentino, MD, FACC, FASH
Guest: Rick Stouffer, MD
Hemodynamic measurements are a crucial component of diagnosing patients with aortic stenosis and evaluating their need for valve replacement surgery. Dr. Rick Stouffer, Professor of Medicine and Cardiology at the University of North Carolina School of Medicine, underscores the value of hemodynamics in managing aortic stenosis, distinguishing critical disease from low-gradient or pseudo-aortic stenosis and cardiac dysfunction.

May 1, 2008 • 0sec
Cardiovascular Hemodynamics for the Clinician
Host: Matthew J. Sorrentino, MD, FACC, FASH
Guest: Rick Stouffer, MD
Dr. Rick Stouffer and his collegues at the University of North Carolina in Chapel Hill have written a book entitled “Cardiovascular Hemodynamics for the Clinician” about using hemodynamic information for the diagnosis and management of cardiac disease. He will discuss the role of hemodynamics in assessing patients in both the cardiac catheterization laboratory and the intensive care unit.

May 1, 2008 • 0sec
Stem Cell Therapy: A Major Regulatory Milestone
Host: Bruce Japsen
Guest: Randal Mills, PhD
2008 was a watershed year for stem cell-based treatment, with the first product of this kind going before an FDA review for approval. Learn more from Randal Mills, PhD, chief executive officer of Osiris Therapeutics, as he unveils details of his company’s stem cell-based medicine with host Bruce Japsen. How might the submission of this medicine for FDA approval start us down the path toward an array of stem cell products?

May 1, 2008 • 0sec
Parsing the Debate Over Embryonic Stem Cells
Host: Bruce Japsen
Guest: Randal Mills, PhD
While politicians debate whether there should be federal funding of embryonic stem cells, they might be over-looking a key point: the fact that all of the momentum in stem cell research is not in cells derived from human embryos at all. Randal Mills, the chief executive officer of Osiris Therapeutics tells the Chicago Tribune's Bruce Japsen about how all of the major clinical research in the U.S. is in adult stem cells.

May 1, 2008 • 0sec
The Promise of Stem Cells Reaching Patients
Host: Bruce Japsen
Guest: Randal Mills, PhD
The promise of stem cell research, once deemed a scientists' dream, has turned the corner into real marketed products and looks to soon be a multi-billion-dollar industry. Randal Mills, the chief executive officer of Osiris Therapeutics tells the Chicago Tribune's Bruce Japsen about stem cell products already on the market and how more are soon coming to physicians and their patients.

Apr 30, 2008 • 0sec
Cardiac Implications of an Exercise Prescription
Host: Lee Freedman, MD
Guest: Aaron Baggish, MD
How close are we to tailoring exercise programs to patients based on their level of cardiac health? One study, conducted by Dr. Aaron Baggish, a cardiology fellow at Massachusetts General Hospital and the lead author of research published in the Journal of Applied Physiology, reveals the specific cardiac structure and function changes in a group of university aged athletes when comparing the effects of strength vs. endurance exercise. Your host, Dr. Lee Freedman, discusses with Dr. Baggish the variance observed in ventricular dilation, wall thickness, diastolic function, and other areas between the two groups, and the potential this study could have in the exam room.

Apr 30, 2008 • 0sec
Brain Research & National Defense: How Sleep, Beta Blockers, and Hallucinogens Can Aid the Military
Host: Larry Kaskel, MD
Guest: Jonathon Moreno, PhD
Host Dr. Larry Kaskel talks with medical ethicist and author Dr. Jonathon Moreno about uses of newer brain research in supporting our military. They discuss the impact of sleep deprivation, performance enhancing drugs and hallucinogens. They also consider the use of beta blockers to prevent or reduce the severity of PTSD.

Apr 30, 2008 • 0sec
Hospital Reimbursement Changes Impacting Physicians
Host: Bill Rutenberg, MD
Guest: Robert Wagner, MD
To date hospital reimbursement has not directly impacted staff physicians. According to Dr. Robert Wagner, CMO of Accretive Health, doctors may see changes in the near future that will impact their pay. In this segment, host Bill Rutenberg, MD learns what doctors can do to minimize this outcome.

Apr 30, 2008 • 0sec
Understanding the Revenue Cycle of a Hospital
Host: Bill Rutenberg, MD
Guest: Robert Wagner, MD
Could further educating physicians on the revenue cycle of the hospital increase cash flow? Dr. Robert Wagner, chief medical officer of Accretive Health, suggests that applying six sigma principals to the financial aspects of medicine can greatly improve the bottom line. Physicians should have a vested interest in the reimbursement of the hospital. Dr. Bill Rutenberg hosts.


